𝔖 Bobbio Scriptorium

✦ LIBER ✦

An open-label study to evaluate the safety and efficacy of 1.0 mg/kg subcutaneously administered efalizumab in adults with moderate to severe hand or foot psoriasis

Book ID: 116582868
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 57 KB
Volume: 56
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2006.10.835

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of efalizumab in adu

Efficacy and safety of efalizumab in adults with moderate to severe plaque psoriasis and hand and foot involvement: A prospective, 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 48 KB

An investigator-initiated, open-label st

An investigator-initiated, open-label study evaluating the efficacy and safety of ustekinumab in patients with moderate to severe palmar plantar psoriasis

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Clinical effectiveness and safety experi

Clinical effectiveness and safety experience with efalizumab in the treatment of patients with moderate-to-severe plaque psoriasis in Taiwan: results of an open-label, single-arm pilot study

✍ TF Tsai; MT Liu; YH Liao; D Licu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

An open label study evaluating the safet

An open label study evaluating the safety and efficacy of a 16 week treatment regimen of alefacept in adults with moderate to severe atopic dermatitis

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

An open-label single-center study to ass

An open-label single-center study to assess the safety and efficacy of dose escalation of alefacept 15 mg IM for 6 weeks followed by 6 weeks of 30 mg IM in patients with moderate to severe chronic plaque psoriasis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Study 1: an open-label pilot study evalu

Study 1: an open-label pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in renal allograft recipients on a regimen of maintenance therapy with moderate renal insufficiency

✍ V.Ram Peddi; David J. Cohen; M.Roy First 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 33 KB